Opaleye Management Inc.
CIK 1595855 · Holdings on Sep 30, 2023 · First reported Nov 15, 2023
Top ten holdings
Q3 2023- HROW17.74%
- SLRN13.72%
- OCUL6.61%
- TGTX5.14%
- RYTM4.87%
- 14888U1014.58%
- KROS3.74%
- BHVN3.71%
- CRNX3.58%
- ETON3.30%
Share classes counted separately66.99%
Portfolio value by quarter
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | HROWHARROW INC View history and evidence | $54.53M | 17.74% | 3.79M shares | — | ↗▾ | |
| 02 | SLRNACELYRIN INC View history and evidence | $42.17M | 13.72% | 4.15M shares | — | ↗▾ | |
| 03 | OCULOCULAR THERAPEUTIX INC View history and evidence | $20.31M | 6.61% | 6.47M shares | — | ↗▾ | |
| 04 | TGTXTG THERAPEUTICS INC View history and evidence | $15.80M | 5.14% | 1.89M shares | — | ↗▾ | |
| 05 | RYTMRHYTHM PHARMACEUTICALS INC View history and evidence | $14.97M | 4.87% | 653.00K shares | — | ↗▾ | |
| 06 | 14888U101CATALYST PHARMACEUTICALS INC View history and evidence | $14.09M | 4.58% | 1.21M shares | — | ↗▾ | |
| 07 | KROSKEROS THERAPEUTICS INC View history and evidence | $11.49M | 3.74% | 360.40K shares | — | ↗▾ | |
| 08 | BHVNBIOHAVEN LTD View history and evidence | $11.42M | 3.71% | 439.00K shares | — | ↗▾ | |
| 09 | CRNXCRINETICS PHARMACEUTICALS IN View history and evidence | $11.00M | 3.58% | 370.00K shares | — | ↗▾ | |
| 10 | ETONETON PHARMACEUTICALS INC View history and evidence | $10.13M | 3.30% | 2.43M shares | — | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 15
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| CBAY CYMABAY THERAPEUTICS INC | Non-derivative | — | — | SEC filing ↗ | |
| TBPH THERAVANCE BIOPHARMA INC | Non-derivative | — | — | SEC filing ↗ | |
| 88369M101 THESEUS PHARMACEUTICALS INC | Non-derivative | — | — | SEC filing ↗ |
3 / 15 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1595855 · Period 2023-09-30
Data loaded 2026-09-23 · First reported 2023-11-15
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 307379517
}Research all 40 reported holdings.
This page includes 30 of 40 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 40 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1595855","quarter":"2023Q3","page_size":100}
get_institutional_manager_history
{"cik":"1595855","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.